<VariationArchive RecordType="classified" VariationID="5016" VariationName="NM_021926.4(ALX4):c.504del (p.Asp169fs)" VariationType="Deletion" Accession="VCV000005016" Version="1" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2022-04-25" DateCreated="2018-01-06" MostRecentSubmission="2018-01-06">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="20055" VariationID="5016">
      <GeneList>
        <Gene Symbol="ALX4" FullName="ALX homeobox 4" GeneID="60529" HGNC_ID="HGNC:450" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>11p11.2</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="11" Accession="NC_000011.10" start="44260440" stop="44310139" display_start="44260440" display_stop="44310139" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="11" Accession="NC_000011.9" start="44282277" stop="44331715" display_start="44282277" display_stop="44331715" Strand="-" />
          </Location>
          <OMIM>605420</OMIM>
          <Haploinsufficiency last_evaluated="2020-07-22" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=ALX4">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2020-07-22" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=ALX4">No evidence available</Triplosensitivity>
        </Gene>
      </GeneList>
      <Name>NM_021926.4(ALX4):c.504del (p.Asp169fs)</Name>
      <CanonicalSPDI>NC_000011.10:44275620:A:</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>11p11.2</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="11" Accession="NC_000011.10" start="44275621" stop="44275621" display_start="44275621" display_stop="44275621" variantLength="1" positionVCF="44275620" referenceAlleleVCF="CA" alternateAlleleVCF="C" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="11" Accession="NC_000011.9" start="44297171" stop="44297171" display_start="44297171" display_stop="44297171" variantLength="1" positionVCF="44297170" referenceAlleleVCF="CA" alternateAlleleVCF="C" />
      </Location>
      <ProteinChange>D169fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000011.10" sequenceAccession="NC_000011" sequenceVersion="10" change="g.44275621del" Assembly="GRCh38">
            <Expression>NC_000011.10:g.44275621del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000011.9" sequenceAccession="NC_000011" sequenceVersion="9" change="g.44297171del" Assembly="GRCh37">
            <Expression>NC_000011.9:g.44297171del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_015809.1" sequenceAccession="NG_015809" sequenceVersion="1" change="g.39546del">
            <Expression>NG_015809.1:g.39546del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_021926.4" sequenceAccession="NM_021926" sequenceVersion="4" change="c.504del" MANESelect="true">
            <Expression>NM_021926.4:c.504del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_068745.2" sequenceAccession="NP_068745" sequenceVersion="2" change="p.Asp169fs">
            <Expression>NP_068745.2:p.Asp169fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_1256" sequenceAccession="LRG_1256" change="g.39546del">
            <Expression>LRG_1256:g.39546del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_1256t1" sequenceAccession="LRG_1256t1" change="c.504del">
            <Expression>LRG_1256t1:c.504del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="LRG_1256p1" sequenceAccession="LRG_1256p1" change="p.Asp169fs">
            <Expression>LRG_1256p1:p.Asp169fs</Expression>
          </ProteinExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="CA253385" DB="ClinGen" />
        <XRef Type="Allelic variant" ID="605420.0004" DB="OMIM" />
        <XRef Type="rs" ID="587776614" DB="dbSNP" />
      </XRefList>
      <Comment DataSource="NCBI curation" Type="public">NCBI staff reviewed the sequence information reported in PubMed 11106354 Fig. 4 to determine the location of this allele on the current reference sequence. </Comment>
      <AlleleFrequencyList>
        <AlleleFrequency Value="0.00000" Source="Trans-Omics for Precision Medicine (TOPMed)" />
        <AlleleFrequency Value="0.00001" Source="Exome Aggregation Consortium (ExAC)" />
        <AlleleFrequency Value="0.00001" Source="Trans-Omics for Precision Medicine (TOPMed)" />
        <AlleleFrequency Value="0.00008" Source="NHLBI Exome Sequencing Project (ESP) Exome Variant Server" />
      </AlleleFrequencyList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_021926.4(ALX4):c.504del (p.Asp169fs) AND Parietal foramina 2" Accession="RCV000005319" Version="5">
        <ClassifiedConditionList TraitSetID="1382">
          <ClassifiedCondition DB="MedGen" ID="C1865044">Parietal foramina 2</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2000-12-01" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2000-12-01" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2018-01-06" MostRecentSubmission="2018-01-06">
        <ReviewStatus>no assertion criteria provided</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">11106354</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="1382" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="5735" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Parietal foramina 2</ElementValue>
                <XRef ID="Parietal+foramina+2/9077" DB="Genetic Alliance" />
                <XRef ID="MONDO:0012309" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">PFM2</ElementValue>
                <XRef Type="MIM" ID="609597" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Enlarged parietal foramina are characteristic symmetric, paired radiolucencies of the parietal bones, located close to the intersection of the sagittal and lambdoid sutures, caused by deficient ossification around the parietal notch, which is normally obliterated by the fifth month of fetal development. Enlarged parietal foramina are usually asymptomatic. Meningeal, cortical, and vascular malformations of the posterior fossa occasionally accompany the bone defects and may predispose to epilepsy. In a minority of individuals, headaches, vomiting, or intense local pain are sometimes associated with the defects, especially on application of mild pressure to the unprotected cerebral cortex.</Attribute>
                <XRef ID="NBK1128" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301307</ID>
                <ID Source="BookShelf">NBK1128</ID>
              </Citation>
              <XRef ID="60015" DB="Orphanet" />
              <XRef ID="C1865044" DB="MedGen" />
              <XRef ID="MONDO:0012309" DB="MONDO" />
              <XRef Type="MIM" ID="609597" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="25497" SubmissionDate="2018-01-02" DateLastUpdated="2018-01-06" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="605420.0004_PARIETAL FORAMINA 2" title="ALX4, 1-BP DEL, 504T_PARIETAL FORAMINA 2" />
        <ClinVarAccession Accession="SCV000025497" DateUpdated="2018-01-06" DateCreated="2013-04-04" Type="SCV" Version="4" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2000-12-01">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">In a family segregating parietal foramina-2 (PFM2; 609597), Wuyts et al. (2000) identified a 1-bp deletion at position 504 (c.504delT) of the cDNA (adenosine of start codon +1) resulting in a premature stop codon after 179 amino acids.</Attribute>
              <Citation>
                <ID Source="PubMed">11106354</ID>
              </Citation>
              <XRef DB="OMIM" ID="609597" Type="MIM" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="ALX4" />
          </GeneList>
          <Name>ALX4, 1-BP DEL, 504T</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">1-BP DEL, 504T</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="605420.0004" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">PARIETAL FORAMINA 2</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="25497" TraitType="Disease" MappingType="Name" MappingValue="PARIETAL FORAMINA 2" MappingRef="Preferred">
        <MedGen CUI="C1865044" Name="Parietal foramina 2" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

